• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds.

作者信息

Alfonso Fernando, Nuccio Julio, Cuevas Cecilia, Cárdenas Alberto, Gonzalo Nieves, Jimenez-Quevedo Pilar

机构信息

Department of Interventional Cardiology, Cardiovascular Institute, San Carlos University Hospital, IdISSC, Madrid, Spain.

出版信息

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2875. doi: 10.1016/j.jacc.2013.05.107.

DOI:10.1016/j.jacc.2013.05.107
PMID:24969756
Abstract
摘要

相似文献

1
Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds.生物可吸收血管支架治疗冠状动脉支架内再狭窄
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2875. doi: 10.1016/j.jacc.2013.05.107.
2
First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.依维莫司洗脱生物可吸收血管支架植入治疗药物洗脱支架失败的首例人体描述：光学相干断层扫描的见解
Int J Cardiol. 2013 Oct;168(4):4490-1. doi: 10.1016/j.ijcard.2013.06.127. Epub 2013 Jul 24.
3
Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.生物可吸收血管支架治疗支架内再狭窄：光学相干断层成像的见解。
Can J Cardiol. 2015 Mar;31(3):255-9. doi: 10.1016/j.cjca.2014.11.017. Epub 2014 Nov 22.
4
Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.新生内膜增殖与完全可生物降解血管支架植入术后2年的临床再狭窄相关。
Circ Cardiovasc Imaging. 2014 Jul;7(4):755-7. doi: 10.1161/CIRCIMAGING.114.001727.
5
First three-dimensional optical frequency domain imaging evaluation of a bioabsorbable vascular scaffold implantation in an instent-restenosis 6 years after CYPHER stenting.
Eur Heart J. 2014 Jun 1;35(21):1393. doi: 10.1093/eurheartj/ehu036. Epub 2014 Feb 16.
6
Treatment of coronary stent restenosis with drug-eluting bioabsorbable magnesium scaffolds.
Coron Artery Dis. 2017 Nov;28(7):627-628. doi: 10.1097/MCA.0000000000000517.
7
Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent.生物可吸收血管支架失败的处理：联合应用自膨式支架治疗支架再狭窄与迟发性获得性冠状动脉瘤
Can J Cardiol. 2015 May;31(5):691.e1-3. doi: 10.1016/j.cjca.2014.12.021. Epub 2014 Dec 19.
8
Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis?
Cardiovasc Revasc Med. 2015 Mar;16(2):124-6. doi: 10.1016/j.carrev.2014.07.003. Epub 2014 Jul 31.
9
In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?镍过敏导致的支架内再狭窄：一种可生物吸收的解决方案？
Coron Artery Dis. 2015 Aug;26(5):461-2. doi: 10.1097/MCA.0000000000000233.
10
Bioresorbable vascular scaffold implantation for treatment of recurrent in-stent restenosis: insights from optical coherence tomography.
Int J Cardiol. 2014 Mar 1;172(1):238-9. doi: 10.1016/j.ijcard.2013.12.212. Epub 2014 Jan 8.

引用本文的文献

1
Current Management of In-Stent Restenosis.支架内再狭窄的当前管理
J Clin Med. 2024 Apr 19;13(8):2377. doi: 10.3390/jcm13082377.
2
Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62.MLN4924 通过抑制 neddylation 改善新生内膜增生并通过 p53 和 p62 促进血管平滑肌细胞凋亡。
Cell Death Differ. 2018 Feb;25(2):319-329. doi: 10.1038/cdd.2017.160. Epub 2017 Oct 13.
3
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
糖尿病对药物洗脱支架再植入治疗支架内再狭窄后长期预后的影响。
BMC Cardiovasc Disord. 2017 Jan 6;17(1):16. doi: 10.1186/s12872-016-0445-6.
4
A review of bioresorbable scaffolds: hype or hope?生物可吸收支架综述：炒作还是希望？
Singapore Med J. 2017 Sep;58(9):512-515. doi: 10.11622/smedj.2016178. Epub 2016 Nov 21.
5
In-Stent Restenosis: Pathophysiology and Treatment.支架内再狭窄：病理生理学与治疗
Curr Treat Options Cardiovasc Med. 2016 Feb;18(2):10. doi: 10.1007/s11936-015-0433-7.
6
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.冠状动脉支架内再狭窄的治疗策略：对24项随机试验和4880例患者的系统评价与分层贝叶斯网络荟萃分析
BMJ. 2015 Nov 4;351:h5392. doi: 10.1136/bmj.h5392.